Mirena Does Not Adversely Affect Milk Supply During Lactation
Women who are breastfeeding can safely use the Mirena levonorgestrel-releasing intrauterine system without concern for negative effects on milk supply, and should be encouraged to breastfeed while using this method. 1
Evidence Supporting Safety in Lactation
The most authoritative guidance comes from multiple professional societies and high-quality research demonstrating that levonorgestrel IUDs do not negatively impact breastfeeding:
Guideline Recommendations
The Society for Maternal-Fetal Medicine (2019) explicitly recommends that women considering immediate postpartum LARC be encouraged to breastfeed, as current evidence suggests these methods do not negatively influence lactation (GRADE 1B recommendation). 1 This is a strong recommendation based on moderate-quality evidence prioritizing patient outcomes.
The American Academy of Pediatrics (2014) supports immediate postpartum insertion of IUDs, noting that both ACOG and CDC endorse this practice as safe and effective. 2 While the guidelines note theoretical concerns about progestin effects on breastfeeding for implants, studies have generally found no effects on breastfeeding performance or infant health and growth.
Research Evidence on Milk Supply and Infant Outcomes
The highest quality direct evidence comes from a 2005 randomized controlled trial comparing Mirena (LNG-IUS) versus Copper T380A IUD in 320 lactating women. 3 This study found:
- No significant differences in breastfeeding continuation rates between groups
- Comparable rates of complete weaning, full breastfeeding, and partial breastfeeding
- No differences in infant physical growth parameters or developmental milestones
- High continuation rates (89.3% for Mirena vs 90.9% for copper IUD)
A 2018 randomized trial examining immediate postpartum LNG-IUD placement found no difference in breastfeeding rates at 6,12, and 24 weeks postpartum compared to delayed insertion. 4 The authors concluded that immediate postpartum LNG-IUD placement does not adversely affect breastfeeding.
Clinical Context and Timing
When to Initiate
According to CDC guidance (2015), for postpartum breastfeeding women, the levonorgestrel IUD is classified as:
- Category 2 (advantages generally outweigh risks) for insertion at <21 days postpartum 5
- Category 1 (no restrictions) for insertion at >42 days postpartum 5
The 2024 CDC Selected Practice Recommendations confirm that LNG-IUDs can be inserted anytime, with backup contraception needed for 7 days if inserted >7 days after menses started. 6
Important Nuances
While one older study (1982) found slightly shorter breastfeeding duration with 30 mcg/day levonorgestrel-releasing IUDs compared to copper IUDs (56% vs 79% continuing at 75 days post-insertion), this difference disappeared over time, and both groups actually breastfed 10 weeks longer than their previous breastfeeding experiences. 7 Importantly, Mirena releases only 20 mcg/day initially (declining over time), which is lower than the dose studied.
Research from 1994 suggests that infants as young as 12 weeks can efficiently metabolize levonorgestrel, supporting the safety of introduction at this age. 8
Common Pitfalls to Avoid
- Do not delay contraception counseling: Many women who desire an IUD at delivery do not return for later insertion, leading to unintended pregnancies
- Do not withhold Mirena from breastfeeding women: The evidence clearly supports its safety
- Counsel about amenorrhea: While not related to milk supply, amenorrhea occurs in 10-37% of users and should be discussed as an expected side effect 9
- Consider copper IUD as alternative: If a patient remains concerned despite evidence, the copper IUD provides equally effective contraception with zero hormonal exposure
The preponderance of evidence from guidelines and research demonstrates that Mirena is compatible with successful breastfeeding and does not compromise milk supply or infant outcomes.